IC

Ikarian Capital Portfolio holdings

AUM $494M
1-Year Est. Return 153.64%
This Quarter Est. Return
1 Year Est. Return
+153.64%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$672M
AUM Growth
+$124M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
266
New
Increased
Reduced
Closed

Top Buys

1
+$23.4M
2
+$15.9M
3
+$15.5M
4
XFOR icon
X4 Pharmaceuticals
XFOR
+$15.4M
5
RLMD icon
Relmada Therapeutics
RLMD
+$10.2M

Top Sells

1
+$29.5M
2
+$19.7M
3
+$18.8M
4
BMY icon
Bristol-Myers Squibb
BMY
+$17.9M
5
CLDX icon
Celldex Therapeutics
CLDX
+$15.8M

Sector Composition

1 Healthcare 98.54%
2 Consumer Staples 0.23%
3 Financials 0.12%
4 Industrials 0.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
26
$7.67M 0.26%
445,188
+126,298
27
$7.63M 0.26%
296,965
-766,996
28
$7.21M 0.24%
+17,500
29
$7.2M 0.24%
+1,256,048
30
$6.88M 0.23%
419,573
-265,000
31
$6.82M 0.23%
91,151
+25,000
32
$6.82M 0.23%
1,030,436
-125,000
33
$6.66M 0.22%
224,533
+36,650
34
$6.21M 0.21%
+425,384
35
$6.15M 0.21%
96,198
-53,334
36
$5.62M 0.19%
+26,860
37
$5.57M 0.19%
190,330
+125,330
38
$5.39M 0.18%
+193,368
39
$5.34M 0.18%
+99,508
40
$5.2M 0.17%
25,623
+373
41
$5.18M 0.17%
257,500
+200,000
42
$5.03M 0.17%
426,739
-10,961
43
$4.77M 0.16%
679,473
+37,365
44
$4.74M 0.16%
188,200
-111,800
45
$4.62M 0.16%
217,637
+22,500
46
$4.58M 0.15%
+724,754
47
$4.57M 0.15%
+1,336,412
48
$4.54M 0.15%
37,829
+21,162
49
$4.52M 0.15%
+1,124,872
50
$4.4M 0.15%
400,000
1
2
3 4 5